Skip to main content
ALHC
NASDAQ Finance

Alignment Healthcare Appoints CEO John Kao as Chairman, Adds New EVP, MSO President, and COO

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$18.3
Mkt Cap
$3.8B
52W Low
$11.625
52W High
$23.87
Market data snapshot near publication time

summarizeSummary

Alignment Healthcare announced a major leadership restructuring, with CEO John Kao also becoming Chairman, and the addition of a new EVP of Corporate Affairs, President of MSO, and Chief Operations Officer to bolster its growth and operational capabilities.


check_boxKey Events

  • CEO Assumes Chairman Role

    John Kao, Founder and CEO, has also been named Chairman of the Board, consolidating leadership and maintaining continuity of strategy and execution.

  • New Executive Vice President

    Former Board Chairman Joseph Konowiecki has been appointed Vice Chairman of the Board and Executive Vice President (EVP) of Corporate Affairs, overseeing Human Resources, Legal, and Communications.

  • Key Operational Hires

    Mark Kent joins as President of the Management Services Organization (MSO) and Shane Hochradel as Chief Operations Officer (COO), bringing extensive experience in value-based care and complex healthcare operations to support scaling.

  • Bylaws Amendment

    The Board approved an amendment to the company's bylaws to formally establish the position of Vice Chair of the Board and define its duties.


auto_awesomeAnalysis

Alignment Healthcare has significantly strengthened its executive leadership team, appointing CEO John Kao as Chairman of the Board. This move consolidates leadership while bringing in Joseph Konowiecki as Vice Chairman and EVP of Corporate Affairs, Mark Kent as President of the MSO, and Shane Hochradel as COO. These appointments are designed to enhance operational execution and support the company's long-term growth strategy, particularly in value-based care and complex healthcare operations, following recent strong financial performance.

At the time of this filing, ALHC was trading at $18.30 on NASDAQ in the Finance sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $11.63 to $23.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ALHC - Latest Insights

ALHC
May 12, 2026, 4:34 PM EDT
Filing Type: DEFA14A
Importance Score:
7
ALHC
May 12, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
ALHC
May 12, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
ALHC
Apr 30, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
8
ALHC
Apr 30, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
ALHC
Apr 24, 2026, 10:52 AM EDT
Filing Type: DEF 14A
Importance Score:
7
ALHC
Mar 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
ALHC
Mar 03, 2026, 3:13 PM EST
Filing Type: 424B7
Importance Score:
7
ALHC
Mar 02, 2026, 9:05 PM EST
Source: GlobeNewswire
Importance Score:
7
ALHC
Mar 02, 2026, 4:49 PM EST
Source: Reuters
Importance Score:
7